Article Details
Retrieved on: 2024-06-22 15:30:32
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the FDA approval of Elevidys, a gene therapy by Sarepta Therapeutics, for treating Duchenne muscular dystrophy (DMD). Aligning with the key concept 'Biotech', the tags cover relevant topics such as genetic engineering, biotechnology, and specific DMD treatment details, including the Muscular Dystrophy Association and FDA involvement.
Article found on: www.wvtm13.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here